CAS Number 434283-16-6 ChemSpider 8292400 KEGG D04683 Molar mass 520.021 g/mol | PubChem CID 10116877 UNII 48854OTZ5E Formula C28H30ClN5O3 | |
 | ||
How to pronounce lecozotan
Lecozotan is an investigational drug by Wyeth tested for improvement of cognitive functions of Alzheimer's disease patients. As of June 2008, the first Phase III clinical trial has been completed.
Contents
Method of action
Lecozotan is a competitive, selective 5-HT1A receptor antagonist which enhances the potassium-stimulated release of acetylcholine and glutamate.
References
Lecozotan Wikipedia(Text) CC BY-SA